Pandemic-era NIH grants (FY2019-2024) covering coronavirus, gain-of-function research, mRNA vaccines, biosafety, and related funding flows. Metadata + abstracts from NIH RePORTER.
Get an AI answer drawn only from the NIH Pandemic-Era Grants documents indexed here — every claim cited back to the filing or proceeding it came from. It will tell you plainly when the record doesn't cover your question, rather than guessing.
Roger A. Fielding · BRIGHAM AND WOMEN'S HOSPITAL · 2024 · $438,138 — SUMMARY / ABSTRACT Preserving late-life mobility, defined as the ability to walk safely and independently, is central to maintaining a high quality of life, is critical for the performance of many activities of daily living and is necessary for maintaining physical independence. Therefore, the conti…
Susan W Parker · UNIV OF MARYLAND, COLLEGE PARK · 2024 · $149,676 — PROJECT SUMMARY The Development Core has, as its primary mission, the development, support, and promotion of population research of the highest scientific merit, in line with our four Primary Research Areas: Gender, Family and Social Change, Health in Social Context, Social and Economic Inequality, …
Maria A Oquendo · UNIVERSITY OF PENNSYLVANIA · 2024 · $295,155 — PROJECT SUMMARY Suicide is inherently an affectively charged topic and clinicians often experience anxiety and low self-efficacy in detecting and intervening with those at risk. This anxiety leads to poor implementation of evidence-based suicide screening, assessment, and interventions (SSAIs). Cl…
Yvonne Commodore-Mensah · JOHNS HOPKINS UNIVERSITY · 2024 · $658,161 — Project Summary/Abstract Innovation in chronic disease management is urgently needed to effectively control hypertension (HTN) and diabetes, conditions which affect millions of Americans. Uncontrolled HTN and diabetes cause cardiovascular disease, stroke, chronic kidney disease (CKD), and premature …
Steven M Lipkin · WEILL MEDICAL COLL OF CORNELL UNIV · 2024 · $345,292 — Project 1: Project Summary/Abstract Lynch syndrome (LS) affects ~1.2 million Americans and predisposes them to colorectal cancer (CRC) and other malignancies. LS normal cells acquire somatic second mutations and become DNA mismatch repair deficient (MMRD). MMRD tumors have exceptionally high numb…
George Parsons Langan · UNIVERSITY OF CHICAGO · 2024 · $1,081,907 — PROJECT ABSTRACT (Core 1/C1Facilities@HTRL) Core 1 Facility Management, Maintenance and Operations Core (C1Facilities@HTRL) The Facility Management, Maintenance, and Operations Core will operate the Howard T Ricketts Regional Biocontainment Laboratory (HTRL) A/BSL3 to ensure continuous containment t…
JAY RAPPAPORT · TULANE UNIVERSITY OF LOUISIANA · 2024 · $1,376,860 — The Biosafety Level 3 (BSL-3) Practices Core (Core 2) will support the research goals of the Regional Biocontainment Laboratory (RBL) at the Tulane National Primate Research Center (TNPRC) by continuing to ensure a safe and secure environment for work with high-consequence pathogens. To do so requir…
COULSON KGATHI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · 2024 · $49,352 — Project Summary/Abstract, Data Management and Distribution Core (Core B) The proposed program project aims to close research gaps in antiretroviral treatment for pregnant women and infants living with HIV with four inter-related projects that will require data management and data sharing. The Data M…
W. JOHN BOSCARDIN · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2024 · $344,226 — PROJECT SUMMARY ABSTRACT – Data and Analysis Core (DAC) Research on function and disability in vulnerable older adults involves methodological and analytical challenges. Addressing these challenges often requires specialized expertise and approaches, including methods for working with data ranging f…
Vivian Colon · UNIVERSITY OF PUERTO RICO MED SCIENCES · 2024 · $683,127 — PROJECT SUMMARY/ABSTRACT: ADMINISTRATIVE CORE The CePCHE Administrative Core (AC) will consist of 5 components: (1) administration and finances, (2) monitoring and evaluation, (3) External Advisory Committee (EAC), (4) Internal Advisory Committee (IAC), and (5) training and Outreach/In-Reach. The AC…
Jaime L Matta · PONCE SCHOOL OF MEDICINE · 2024 · $200,815 — ABSTRACT | ADMINISTRATIVE CORE The Administrative Core (AC) of the Ponce Health Sciences University-Moffitt Cancer Center (PHSU-MCC) Partnership serves as its central coordinating component. The AC manages all aspects of the Partnership including day-to-day administrative and financial supervision, …
RICHARD WEBBY · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · 2024 · $602,070 — CEIRR will determine the molecular, ecologic and/or environmental factors that influence the evolution, emergence, transmission and pathogenicity of respiratory viruses, including coronaviruses such as SARS-CoV-2, and characterize the immune response to infection to improve understanding of the immu…
RALPH BARIC · UNIV OF NORTH CAROLINA CHAPEL HILL · 2024 · $563,541 — This contract provides for the development of new and refinement of existing models of infectious diseases and may include evaluation of candidate countermeasures.…
Florian Krammer · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · 2024 · $119,920 — PROJECT 1: ABSTRACT Current information indicates that, in persons without cancer, natural infection with SARS-CoV-2 as well as vaccination with COVID-19 vaccine candidates induce antibody responses to the spike protein of the virus which should be protective against future infection. Lung cancer pa…
MADHAV V DHODAPKAR · EMORY UNIVERSITY · 2024 · $88,878 — Abstract: The Emory U54 SeroNET U54 program is a multidisciplinary program that brings together experienced team of investigators to tackle fundamental issues relating to immunity to SARS CoV-2, particular in patients with cancer and autoimmunity. The team has a long track record of prior work in ba…
KEVIN URDAHL · SEATTLE CHILDREN'S HOSPITAL · 2024 · $5,443,065 — The goal of this program is to establish an integrated multi-disciplinary team of highly collaborative investigators that will plan and conduct iterative, in-depth immunologic analyses of tissue-specific and systemic responses in small animals, non-human primates (NHPs), and humans to identify the k…
Liya Escalera · UNIVERSITY OF MASSACHUSETTS BOSTON · 2024 · $369,198 — PROJECT SUMMARY The UMass Boston Dana-Farber/Harvard Cancer Center Partnership’s Research Education Core (REC) aims to bridge the divide that exists in the biomedical workforce by increasing the number of UMass Boston students, particularly those from underrepresented populations, to pursue graduat…
CASEY LONG · DYNPORT VACCINE COMPANY, LLC · 2024 · $245,549 — The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases and can carry out all aspects of interventional clinical trial implementation.…
BRETT HURST · UTAH STATE UNIVERSITY · 2024 · $206,532 — This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.…
DENNIS CARSON · UNIVERSITY OF CALIFORNIA, SAN DIEGO · 2024 · $2,601,750 — The offeror’s proposed work plan aims to identify, characterize and optimize non-toxic, low molecular weight agents as adjuvants that a) enhance protein antigen accumulation and release in non-immune and immune cells after intramuscular administration of mRNA vaccine and b) stimulate innate immune…